Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Proactively manage your pharmacy inventory
Find generic entry opportunities
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Tableting of colestipol hydrochloride|
|Abstract:||The present invention provides a novel formulation of matter and a novel process for making it. In particular, the present invention provides unique and novel 1000 mg tablets of Colestipol hydrochloride having the advantageous properties of hardness and low friability and a novel process for making such tablets.|
|Inventor(s):||Shen; Robert W. (Kalamazoo, MI), Price; Jeffrey E. (Schoolcraft, MI)|
|Assignee:||The Upjohn Company (Kalamazoo, MI)|
Patent Claim Types:|
see list of patent claims
|Compound; Dosage form; Process;|
|PCT Filed||June 23, 1992||PCT Application Number:||PCT/US92/05066|
|PCT Publication Date:||January 21, 1993||PCT Publication Number:||WO93/00915|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||173931||<disabled in preview>|
|Australia||2293392||<disabled in preview>|
|Australia||669664||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.